Valuation Boston Scientific Corporation
Stocks
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
Pre-market 06:59:32 pm | |||
| 44.99 USD | +0.40% |
|
44.32 | -1.48% |
| 08/07 | Needham Cuts Price Target on Boston Scientific to $57 From $77, Keeps Buy Rating | MT |
| 06/07 | Evercore ISI Adjusts Boston Scientific Price Target to $65 From $78 | MT |
Company Valuation: Boston Scientific Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 60,534 | 66,273 | 84,691 | 1,31,642 | 1,41,351 | 66,871 | - | - |
| Change | - | 9.48% | 27.79% | 55.44% | 7.37% | -52.69% | - | - |
| Enterprise Value (EV) 1 | 67,674 | 74,280 | 92,928 | 1,41,974 | 1,50,822 | 74,030 | 70,947 | 67,444 |
| Change | - | 9.76% | 25.1% | 52.78% | 6.23% | -50.92% | -4.16% | -4.94% |
| P/E | 61.6x | 103x | 54x | 71.5x | 49.1x | 16.5x | 15.7x | 13.9x |
| PBR | 3.64x | 3.77x | 4.39x | 6.05x | 5.84x | 2.36x | 2.11x | 1.9x |
| PEG | - | -3x | 0x | 4.3x | 0.9x | 0.4x | 3.02x | 1.1x |
| Capitalization / Revenue | 5.09x | 5.23x | 5.95x | 7.86x | 7.04x | 3.1x | 2.87x | 2.65x |
| EV / Revenue | 5.69x | 5.86x | 6.53x | 8.48x | 7.51x | 3.43x | 3.04x | 2.68x |
| EV / EBITDA | 16.5x | 20.8x | 22.6x | 29.3x | 25.3x | 11.1x | 9.71x | 8.43x |
| EV / EBIT | 22.5x | 22.9x | 24.9x | 31.3x | 26.9x | 12.1x | 10.6x | 9.3x |
| EV / FCF | 51.4x | 79.2x | 51.9x | 53.7x | 41.2x | 18x | 17x | 12.8x |
| FCF Yield | 1.94% | 1.26% | 1.93% | 1.86% | 2.43% | 5.56% | 5.9% | 7.79% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.69 | 0.45 | 1.07 | 1.25 | 1.94 | 2.722 | 2.864 | 3.227 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 11,888 | 12,682 | 14,240 | 16,747 | 20,074 | 21,577 | 23,323 | 25,198 |
| EBITDA 1 | 4,103 | 3,574 | 4,106 | 4,839 | 5,973 | 6,698 | 7,303 | 8,005 |
| EBIT 1 | 3,010 | 3,241 | 3,738 | 4,529 | 5,612 | 6,122 | 6,665 | 7,254 |
| Net income 1 | 985 | 642 | 1,570 | 1,853 | 2,898 | 3,877 | 4,119 | 4,640 |
| Net Debt 1 | 7,140 | 8,007 | 8,237 | 10,332 | 9,471 | 7,159 | 4,076 | 573.2 |
| Reference price 2 | 42.48 | 46.27 | 57.81 | 89.32 | 95.35 | 44.99 | 44.99 | 44.99 |
| Nbr of stocks (in thousands) | 14,24,992 | 14,32,311 | 14,64,983 | 14,73,827 | 14,82,442 | 14,86,355 | - | - |
| Announcement Date | 02/02/22 | 01/02/23 | 31/01/24 | 05/02/25 | 04/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 16.53x | 3.43x | 11.05x | -.--% | 6.69TCr | |
| 26.27x | 4.73x | 18.22x | 0.35% | 19TCr | |
| 45.51x | 11.84x | 26.5x | -.--% | 15TCr | |
| 32.57x | 7.28x | 23.14x | -.--% | 5.26TCr | |
| 18.15x | 2.09x | 10.82x | 2.89% | 4.38TCr | |
| 25.95x | 5.17x | 17.68x | 0.77% | 3.77TCr | |
| 45.71x | 6.38x | 19.59x | -.--% | 3.7TCr | |
| 19.66x | 5.17x | 13.33x | 1.17% | 3.01TCr | |
| 14.53x | 1.62x | 9.08x | 0.24% | 2.94TCr | |
| 41.34x | 6.53x | 23.23x | -.--% | 2.93TCr | |
| Average | 28.62x | 5.42x | 17.26x | 0.54% | 6.68TCr | |
| Weighted average by Cap. | 30.37x | 6.26x | 18.85x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BSX Stock
- Valuation Boston Scientific Corporation
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition